Annual EBITDA
-$234.03 M
-$74.59 M-46.78%
December 31, 2021
Summary
- As of February 10, 2025, TPTX annual EBITDA is -$234.03 million, with the most recent change of -$74.59 million (-46.78%) on December 31, 2021.
- During the last 3 years, TPTX annual EBITDA has fallen by -$208.53 million (-817.70%).
Performance
TPTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$123.05 M
-$49.37 M-67.00%
June 30, 2022
Summary
- As of February 10, 2025, TPTX quarterly EBITDA is -$123.05 million, with the most recent change of -$49.37 million (-67.00%) on June 30, 2022.
- Over the past year, TPTX quarterly EBITDA has dropped by -$67.24 million (-120.49%).
Performance
TPTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$339.54 M
-$67.24 M-24.69%
June 30, 2022
Summary
- As of February 10, 2025, TPTX TTM EBITDA is -$339.54 million, with the most recent change of -$67.24 million (-24.69%) on June 30, 2022.
- Over the past year, TPTX TTM EBITDA has dropped by -$183.05 million (-116.97%).
Performance
TPTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TPTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.8% | -120.5% | -117.0% |
| 3 y3 years | -817.7% | -578.6% | -345.9% |
| 5 y5 years | -1304.3% | -2441.3% | -345.9% |
TPTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | +67.0% | at low | +45.1% | at low |
| 5 y | 5-year | +207.4% | at low | +586.1% | at low | +345.9% | at low |
| alltime | all time | +1304.3% | at low | +2441.3% | at low | +6912.4% | at low |
Turning Point Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$123.05 M(+67.0%) | -$339.54 M(+24.7%) |
| Mar 2022 | - | -$73.68 M(-4.8%) | -$272.30 M(+16.4%) |
| Dec 2021 | -$234.03 M(+46.8%) | -$77.37 M(+18.2%) | -$234.03 M(+14.7%) |
| Sep 2021 | - | -$65.44 M(+17.3%) | -$204.00 M(+30.4%) |
| Jun 2021 | - | -$55.81 M(+57.6%) | -$156.49 M(+17.8%) |
| Mar 2021 | - | -$35.42 M(-25.2%) | -$132.82 M(-16.7%) |
| Dec 2020 | -$159.44 M | -$47.33 M(+163.9%) | -$159.44 M(+18.4%) |
| Sep 2020 | - | -$17.93 M(-44.2%) | -$134.63 M(-2.7%) |
| Jun 2020 | - | -$32.14 M(-48.2%) | -$138.36 M(+11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$62.04 M(+175.5%) | -$124.36 M(+63.3%) |
| Dec 2019 | -$76.14 M(+198.6%) | -$22.52 M(+3.9%) | -$76.14 M(+20.8%) |
| Sep 2019 | - | -$21.67 M(+19.5%) | -$63.04 M(+32.8%) |
| Jun 2019 | - | -$18.13 M(+31.1%) | -$47.47 M(+37.6%) |
| Mar 2019 | - | -$13.83 M(+47.0%) | -$34.49 M(+35.2%) |
| Dec 2018 | -$25.50 M(+53.0%) | -$9.41 M(+54.1%) | -$25.50 M(+58.4%) |
| Sep 2018 | - | -$6.10 M(+18.5%) | -$16.10 M(+61.1%) |
| Jun 2018 | - | -$5.15 M(+6.4%) | -$9.99 M(+106.4%) |
| Mar 2018 | - | -$4.84 M | -$4.84 M |
| Dec 2017 | -$16.67 M | - | - |
FAQ
- What is Turning Point Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Turning Point Therapeutics?
- What is Turning Point Therapeutics annual EBITDA year-on-year change?
- What is Turning Point Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Turning Point Therapeutics?
- What is Turning Point Therapeutics quarterly EBITDA year-on-year change?
- What is Turning Point Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Turning Point Therapeutics?
- What is Turning Point Therapeutics TTM EBITDA year-on-year change?
What is Turning Point Therapeutics annual EBITDA?
The current annual EBITDA of TPTX is -$234.03 M
What is the all time high annual EBITDA for Turning Point Therapeutics?
Turning Point Therapeutics all-time high annual EBITDA is -$16.67 M
What is Turning Point Therapeutics annual EBITDA year-on-year change?
Over the past year, TPTX annual EBITDA has changed by -$74.59 M (-46.78%)
What is Turning Point Therapeutics quarterly EBITDA?
The current quarterly EBITDA of TPTX is -$123.05 M
What is the all time high quarterly EBITDA for Turning Point Therapeutics?
Turning Point Therapeutics all-time high quarterly EBITDA is -$4.84 M
What is Turning Point Therapeutics quarterly EBITDA year-on-year change?
Over the past year, TPTX quarterly EBITDA has changed by -$67.24 M (-120.49%)
What is Turning Point Therapeutics TTM EBITDA?
The current TTM EBITDA of TPTX is -$339.54 M
What is the all time high TTM EBITDA for Turning Point Therapeutics?
Turning Point Therapeutics all-time high TTM EBITDA is -$4.84 M
What is Turning Point Therapeutics TTM EBITDA year-on-year change?
Over the past year, TPTX TTM EBITDA has changed by -$183.05 M (-116.97%)